Stock Market Plunges as Trump’s Cabinet Picks Spark Economic Fears
Following the announcement of a key political appointment, Novavax and BioNTech experienced significant stock drops exceeding 7%, while Moderna reached its 2024 low. Pfizer saw more moderate losses. This market reaction follows the pharmaceutical industry’s substantial campaign donations to both parties, albeit with a greater contribution to Republicans. However, growing investor concern over the potential long-term economic costs of certain policies is contributing to broader market declines.
John Q. Hosedrinker